These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 38198884

  • 1. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
    West RE, Oberly PJ, Riddler SA, Nolin TD, Devanathan AS.
    J Pharm Biomed Anal; 2024 Mar 15; 240():115932. PubMed ID: 38198884
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
    West RE, Oberly PJ, Saylor AJ, Riddler SA, Nolin TD, Devanathan AS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul 01; 1241():124164. PubMed ID: 38823149
    [Abstract] [Full Text] [Related]

  • 3. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P, Alves Saldanha S, Cavassini M, Marzolini C, Choong E, Csajka C, Günthard HF, André P, Buclin T, Desfontaine V, Decosterd LA.
    J Mass Spectrom; 2020 Jun 01; 55(6):e4506. PubMed ID: 32160389
    [Abstract] [Full Text] [Related]

  • 4. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring.
    West RE, Oberly PJ, Riddler SA, Nolin TD, Devanathan AS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov 15; 1230():123905. PubMed ID: 37866010
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV.
    Thoueille P, Seybold U, Decosterd LA, Desfontaine V.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan 01; 1214():123575. PubMed ID: 36542988
    [Abstract] [Full Text] [Related]

  • 6. UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma.
    Gouget H, Noé G, Barrail-Tran A, Furlan V.
    J Pharm Biomed Anal; 2020 Mar 20; 181():113057. PubMed ID: 31962247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.
    Bollen PDJ, de Graaff-Teulen MJA, Schalkwijk S, van Erp NP, Burger DM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan 15; 1105():76-84. PubMed ID: 30572204
    [Abstract] [Full Text] [Related]

  • 9. UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
    Simiele M, Ariaudo A, De Nicolò A, Favata F, Ferrante M, Carcieri C, Bonora S, Di Perri G, De Avolio A.
    J Pharm Biomed Anal; 2017 May 10; 138():223-230. PubMed ID: 28219799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
    Quaranta S, Woloch C, Paccou A, Giocanti M, Solas C, Lacarelle B.
    Ther Drug Monit; 2009 Dec 10; 31(6):695-702. PubMed ID: 19865000
    [Abstract] [Full Text] [Related]

  • 12. Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV.
    Rigo-Bonnin R, García-Tejada L, Mas-Bosch V, Imaz A, Manuel Tiraboschi J, Scévola S, Niubó J, Navarro-Alcaraz A, Podzamczer D.
    Clin Chim Acta; 2024 Jan 01; 552():117678. PubMed ID: 38042460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E.
    Lancet; 2017 Nov 04; 390(10107):2063-2072. PubMed ID: 28867497
    [Abstract] [Full Text] [Related]

  • 18. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
    Tachet J, Versace F, Mercier T, Buclin T, Decosterd LA, Choong E, Girardin FR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov 15; 1230():123917. PubMed ID: 37956468
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection.
    Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA.
    Ther Drug Monit; 2011 Apr 15; 33(2):209-13. PubMed ID: 21297550
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.